Jeroen van den Hout | CEO | LivAssured
Jeroen van den Hout is an entrepreneur with over 25 years of experience building innovative start-ups and scale-ups in medtech. He founded and co-founded pioneering companies in 3D printing, digital dentistry, and neonatology.
He is currently CEO of LivAssured, developer of NightWatch, a wearable medical device that detects potentially dangerous epileptic seizures during sleep. Under his leadership, the company scaled from market introduction to a profitable medtech leader in home epilepsy monitoring across Europe.
In October 2025, LivAssured was acquired by MedCap/Abilia, a publicly listed Swedish Assistive Tech group.
NightWatch+ includes a comfortable, wireless sensor that continuously monitors to detect seizures using heart rate and movements while the wearer sleeps. NightWatch+ is intended to be used at home or residential care facilities by people diagnosed with epilepsy aged 4 years and older, having nocturnal epileptic motor seizures and caregivers thereof. When NightWatch+ detects a potentially dangerous seizure, a warning is transmitted via a wireless signal from the sensor to the corresponding alarm station to notify a caregiver.
NightWatch+ seizure detection technology was invented and developed in collaboration with a consortium of Dutch neurologists, patient organizations, universities, and high-tech industries. It comes highly recommended by patients.
| Powered by: Hyphen Projects | Connect | Join Global Investor Forum | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
|
REGISTER NOW
SUBSCRIBE TO OUR NEWSLETTER
|
© Copyright 2025 by Hyphen Projects